Discover supporting research and information on how cannabidiol (CBD) relates to the treatment of Fibromyalgia.

Fibromyalgia or fibrositis is the second most common condition affecting the bones and muscles. This common condition is seen in almost 3 million people per year - the large majority being women. Fibromyalgia is a rheumatic disorder meaning it causes chronic, often intermittent pain in the joints and/or connective tissue.

This disorder most commonly affects those age 20 and older with 80-90% of cases being in women. It has no cure, but the painful symptoms can be managed through exercise, stress reduction, regulating diet and medication. Many who suffer from the condition are able to live a normal, active life by managing the symptoms.


Fibromyalgia is commonly known by the 'all over aching' of tender points on the body, commonly around the neck, shoulders, and hips and other joints. Common symptoms include:


The exact cause of fibro is currently unknown, though the root of the condition has been suggested to be a problem with central pain processing in the brain. This may result in a sensitivity and/or perception of pain.

The following factors may increase the risk of being diagnosed with fibromyalgia:

Treating Fibromyalgia with CBD

Currently, research on CBD as it relates to fibromyalgia is scarce, yet very encouraging. Research suggests that cannabis-based medicines may be effective in treating fibromyalgia and it's associated symptoms with few adverse effects. Positive research results stem from the use of full-spectrum, whole-plant cannabis medicines with a synthetic CBD molecule (nabilone) being ineffective. (3)

Anecdotal evidence supports these research findings showing that CBD, when taken daily in a full-spectrum whole-plant form, can help manage fibromyalgia-related pain and associated symptoms. These same reports show that CBD alone may not help with pain reduction. The inclusion of CBD, THC, plus other naturally occurring cannabinoids and terpenes promote superior relief thanks to the entourage effect.

Notable Research Summary


Research does not point to specific dosage recommendations. Standard dosages likely apply.

For more information, see our dosage guidelines for CBD.

Supporting Research

  1. Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? (April 2008) –
  2. Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life. (April 2011) –
  3. Cannabinoids for fibromyalgia. (July 2016) –
  4. The Consumption of Cannabis by Fibromyalgia Patients in Israel. (July 2018) –
  5. Medical Cannabis for the Treatment of Fibromyalgia. (August 2018) –

The contents of this page are not medical advice. Please seek professional medical assistance for any condition and before starting, stoping, or changing medication or supplements.